Spiral is excited to combine our team and technology with Omicia’s. We have come together to create the most advanced, end-to-end bioinformatics solution in healthcare. Clinical diagnostic organizations and researchers use our solutions to analyze and derive clinically relevant insights from genomic data.
Together we are unlocking the potential of individualized medicine. Our mission is to help researchers and clinicians understand and apply the most relevant information from next-generation sequencing (NGS) data, to improve disease management and medical outcomes. Spiral’s advanced tools add multiple variant detection capabilities for NGS to Omicia’s industry-leading software platform. Access to Omicia’s diverse customer base, global market position, and market-leading platform will help define the future of healthcare.
As a company, we value technological and scientific excellence and are constantly pushing the envelope.
To read the full press release announcing the acquisition of Spiral by Omicia, click here.